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Abstract
Objective: This retrospective study was conducted to determine the incidence of various
complications of Plasmodium vivax malaria based on review of case records.
Methods: The case records of all confirmed cases of malaria over the period of one year (September
2005–August 2006) were studied. Complete blood count, peripheral blood findings, liver and kidney
functions were reviewed. The results of rapid diagnostic test for malaria (OptiMAL test, Diamed
AG, Switzerland) were correlated with the peripheral blood smear findings in the patients in whom
it was requested.  All abnormal results like a positive direct Coomb’s test were noted. Findings
were clinically correlated.
Results: There were 265 confirmed cases by peripheral blood examination. Of these 221 were due
to Plasmodium vivax and 41 due to P.  falciparum. Two cases had mixed infection and in one case
the species could not be identified as it showed only malarial pigment. The peak incidence of
malaria was seen in September 2005 and August 2006. The complications in P. vivax were
thrombocytopenia, biochemical evidence of hepatic dysfunction, renal damage, positive DCT and
death due to ARDS. Thrombocytopenia was seen in 213 patients with counts < 20 x 103/μl in 13
patients. Nine (4%) patients had serum bilirubin >3 mg/dl with normal liver enzymes. Liver enzymes
were elevated in 60 patients with seven patients showing liver enzymes level, three times the normal.
Renal dysfunction was seen in 17 patients with serum creatinine ranging from 1.3–10.65 mg/dl.
One patient went into acute renal failure following quinine therapy and showed red cell fragments
in the peripheral blood. In two children DCT was positive with the peripheral smear showing RBC
agglutinates around the parasitised RBC.  There were three maternal deaths at about 32 weeks
gestation due to ARDS. The peripheral blood smear in these patients showed WBC agglutinates.
Conclusion: This paper is presented to highlight that P. vivax malaria though considered to be a
benign entity can also have a severe and complicated course which is usually associated with P.
falciparum malaria.
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Introduction
Malaria is a well-known cause of morbidity and mor-
tality in India. Among the four species of Plasmo-
dium, Plasmodium falciparum and P. vivax are
commonly found in our country and only few cases
of P. malariae have been reported from Orissa and
Karnataka1. Benign tertian malaria is an acute febrile
illness caused by P. vivax in which the paroxysm of
fever comes every third-day (48 h). It usually has a
benign course. Classically, severe malaria is caused
by P. falciparum. Literature, however, shows iso-
lated reports of severe P. vivax malaria associated
with thrombocytopenia, cerebral malaria, dissemi-
nated intravascular coagulation, acute respiratory
distress syndrome (ARDS), hepatic dysfunction and
renal involvement2–14. This is a retrospective study
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of P. vivax malaria based on review of case records.
Material & Methods
The case records of all the patients of P. vivax ma-
laria cases admitted to St. Stephen’s Hospital, Delhi
from September 2005–August 2006 were studied.
Complete blood count and peripheral blood findings,
liver and kidney function tests were reviewed. The
results of rapid diagnostic test for malaria (OptiMAL
test, Diamed AG, Switzerland) were correlated with
the peripheral blood smear findings in the patients in
whom it was requested. Additional abnormal results
like a positive direct Coomb’s test were noted. All
abnormal laboratory results were clinically corre-
lated.
Results
The peak incidence of malaria was seen in the month
of September 2005 followed by August 2006 (Fig.
1). There were a total of 265 cases of malaria, 221
were due to P. vivax, 41 caused by P. falciparum, two
cases of mixed infection and in one case the species
could not be identified as the blood smear showed
only malarial pigment. Among the patients with P.
vivax malaria, 161 were males and 60 were females
with age ranging from two months to 75 years (me-
dian age 32 years). Thirty-seven patients were in the
paediatric age group in the age ranging from two
months to 12 years (median age 3 years). Thromb-
ocytopenia was present in 213 (96.3%) patients and
of which 13(6%) patients had a count <2 0 x 103/μl.
Sixty (27.1%) patients showed hepatic dysfunction
based on raised liver enzymes.  SGOT ranged from
43–1901 U/l and SGPT ranged from 44–848 U/l.
Seven patients had liver enzymes three times the
normal level. Nine (4%) patients had serum bilirubin
>3 mg/dl with normal liver enzymes. Seventeen (7%)
patients had serum creatinine above 1.2 mg/dl. One
patient went into acute renal failure with serum crea-
tinine of 10.64 mg/dl and her peripheral blood smear
showed red cell fragments and microspherocytes
(Fig. 2a).  Two children had positive direct Coomb’s
test with the smear showing agglutination of red
blood cells around the parasitized RBC (Fig. 2b).
Three maternal deaths occurred due to ARDS, diag-
nosis based on blood gas analysis, chest radiograph
and normal central venous pressure. The peripheral
blood smear showed heavy parasitaemia with >5%
RBCs parasitized and WBC agglutinates.  Phagocy-
tosed parasites were seen in the neutrophils (Figs. 2c
and d).  Rapid diagnostic test for malaria based on
specific Plasmodium LDH antigen (OptiMAL test)
was done on 21 of these patients. Sixteen patients
were positive for P. vivax and five were positive for
P. falciparum. There was no discrepancy in the di-
agnosis between peripheral blood smear examination
and the  rapid diagnostic test.
Fig. 1: Incidence of malaria in St. Stephen’s Hospital, Delhi,
India
Fig. 2:  (a) Red cell fragments and microspherocytes; (b)
Agglutination of RBCs around parasitized RBC;  (c)
WBC agglutinates; and (d) WBC agglutinate with
phagocytosed parasite
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Discussion
Malaria is a common infection in most parts of the
world. Benign tertian malaria generally has an un-
complicated course but sporadically, all complica-
tions usually associated with P. falciparum malaria
have also been reported in vivax malaria2–14.  Pro-
found thrombocytopenia is a well recognized com-
plication of falciparum malaria but there have been
conflicting reports regarding thrombocytopenia in
vivax malaria3,5,6. In our study, thrombocytopenia
was a common finding in the patients with vivax
malaria. Direct lytic effect, immunological reactions,
splenic sequestration and oxidative stress are some
of the suggested mechanisms for thrombocytope-
nia15–17. Although 96.3% of our patients had low
platelets, none of them had bleeding complications
and hence did not require platelet transfusion. There
is a paucity of reports of hepatic dysfunction in be-
nign tertian malaria7. Malarial hepatitis has been
well-described in falciparum malaria8,9. In our study
group 4% of patients had only indirect bilirubinemia
suggesting haemolysis and 27.1% patients had raised
liver enzymes indicative of “malarial hepatitis” due
to direct hepatic injury by the parasite. All patients
with P. vivax malaria were screened for G6PD en-
zyme deficiency before starting primaquine therapy
and showed normal activity of the enzyme. This
rules out a possibility of oxidant haemolysis in these
patients as cause of indirect bilirubinemia. Renal
manifestations of malaria have a wide spectrum.
Though renal involvement is more common in
falciparum malaria, there have been reports of acute
renal failure, electrolyte abnormality, abnormal uri-
nary sediment, and increased urinary protein excre-
tion in vivax malaria10,11. Seven percent of  patients
had raised serum creatinine and one patient went into
acute renal failure in our study. This patient had re-
ceived quinine hydrochloride and the peripheral
blood smear showed red cell fragments and
microspherocytes. Quinine associated haemolytic
uremic syndrome is known to occur18. Two children
had positive direct Coomb’s test with the smear
showing agglutination of red cells around the para-
sitized RBC ruling out a false positive test as previ-
ously reported in literature19. Respiratory complica-
tion in P. vivax malaria seem to be underdiagnosed.
Acute non-cardiogenic pulmonary oedema, ARDS,
acute pulmonary injury and interstitial pneumonia
are some of the reported complications14. Small air-
way obstruction, gas exchange alteration, increased
phagocytic activity and accumulation of pulmonary
monocytes are the suggested mechanisms13. In our
study group, three maternal deaths occurred due to
ARDS. The diagnosis was based on blood gas analy-
sis, chest radiograph and normal central venous pres-
sure. The patients had heavy parasitaemia with WBC
agglutinates which showed phagocytosed parasites.
It is postulated that these WBC agglutinates produce
the ARDS. None of the patients presented with ce-
rebral malaria.
This paper highlights that thrombocytopenia, hepatic
dysfunction, renal involvement and ARDS do com-
plicate benign tertian malaria. Close monitoring of
such patients for respiratory complications should be
done since ARDS appears to be associated with a
fatal outcome and aggressive exchange transfusions
to decrease the parasitic load and WBC agglutinates
may be beneficial and life-saving.
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